Altaire Pharmaceuticals, Inc. recalls Altaire Ciprofloxacin Ophthalmic Solution, USP, 0.3%, Rx only 2.5 mL, Altaire Pharmaceuticals, Inc Aquebogue, NY 11931 N
Recalled November 27, 2019 · FDA recall D-0419-2020 · Altaire Pharmaceuticals
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
3060 units
Sold at
U.S.A. Nationwide
Description
Lack of Assurance of Sterility
Product
Altaire Ciprofloxacin Ophthalmic Solution, USP, 0.3%, Rx only 2.5 mL, Altaire Pharmaceuticals, Inc Aquebogue, NY 11931 NDC 59390-217-02
Manufacturer(s)
Altaire Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →